HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 2.88
Day range
kr 2.85 - kr 3.12
Year range
kr 2.00 - kr 17.98
Market cap
282.55M SEK
Avg Volume
712.28K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.01M | 89.52% |
Net income | -28.33M | -167.31% |
Net profit margin | — | — |
Earnings per share | -0.29 | 6.45% |
EBITDA | -21.99M | -89.66% |
Effective tax rate | 0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.26M | 244.34% |
Total assets | 140.92M | 61.84% |
Total liabilities | 61.98M | 386.32% |
Total equity | 78.94M | — |
Shares outstanding | 96.09M | — |
Price to book | 3.51 | — |
Return on assets | -36.40% | — |
Return on capital | -46.14% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -28.33M | -167.31% |
Cash from operations | -18.78M | -17.94% |
Cash from investing | — | — |
Cash from financing | -1.98M | -797.73% |
Net change in cash | -20.46M | -19.40% |
Free cash flow | -8.83M | 33.02% |
About
Founded
1999
Website
Employees
13
